Stabilized antimicrobial compositions and methods of use

Abstract

An antimicrobial composition including from about 3 g to about 10 g of a first component, from about 0.5 g to about 1.625 g of a second component, and 3786 mL of water. The first component includes from about 0.8 g to about 5 g of the following benzyl ammonium salts: from about 0.04 g to about 0.2 g of C12 dimethyl benzyl ammonium chloride; from about 0.50 g to about 5.0 g of C14 dimethyl benzyl ammonium chloride; and from about 0.064 g to about 0.6 g of C16 dimethyl benzyl ammonium chloride. The first component further includes from about 0.8 g to about 2 g of the following ethylbenzyl ammonium salts: from about 0.02 g to about 1.3 g of C12 dimethyl ethylbenzyl ammonium chloride; and from about 0.01 g to about 0.64 g of C14 dimethyl ethylbenzyl ammonium chloride. The first component further includes from about 0.10 g to about 6 g of urea. The second component includes trichloromelamine.

Description

[0001]This application claims benefit of U.S. Provisional Patent Application No. 62 / 298,615, filed Feb. 23, 2016, entitled “Stabilized Antimicrobial Compositions and Methods of Use”, which is incorporated herein by reference.BACKGROUND OF THE INVENTION[0002]Field of the Invention[0003]The embodiments of the present invention relate to antimicrobial compositions, and more particularly, the embodiments of the present invention relate to a stabilized antimicrobial compositions and methods of use.[0004]Description of the Prior Art[0005]The CDC has estimated that 4% of all patients entering hospitals or medical facilities will acquire an infection while in the hospital. Multiple studies have demonstrated that surfaces in the rooms of patients colonized or infected with important healthcare associated pathogens are frequently contaminated, with1 ranges varying between 1% to 70% . . . and less than 50% of hospital room surfaces are adequately cleaned and disinfected when chemical germicide...

AI Technical Summary

Benefits of technology

The present invention provides stabilized antimicrobial compositions that can effectively control and eliminate cross-contamination of pathogenic organisms on environmental surfaces. The compositions include alkyl aryl ammonium chlorides, chloro amine triazine, and a diamide of carbonic acid. The premeasured dosing eliminates potential human error, and the powdered composition has a longer shelf life and stability.

Problems solved by technology

Current products and application methods are cumbersome with varying results.

Furthermore, even though these innovations may be suitable for the specific individual purposes to which they address, nevertheless, they would not be suitable for the purposes of the embodiments of the present invention as heretofore described.

Images